Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Ashok Kumar Manickaraj"'
Autor:
Marie A. Chaix, James Ellis, Cedric Manlhiot, Emily Lam, Paul C. Nathan, Neha Parmar, Anne Christie, Jane Lougheed, Paul F. Kantor, Guoliang Meng, Luc Mertens, Anastasia Miron, Leonard S. Sender, Stacey Marjerrison, Shayna Zelcer, Ashok Kumar Manickaraj, David C. Hodgson, Rejane Dillenburg, Seema Mital, Oyediran Akinrinade, Herschel Rosenberg, Roderick Yao, Caroline Kinnear, Myriam Lafreniere-Roula, Mylene Bassal
Publikováno v:
Paediatrics Publications
JACC: CardioOncology
JACC: CardioOncology
Background Despite known clinical risk factors, predicting anthracycline cardiotoxicity remains challenging. Objectives This study sought to develop a clinical and genetic risk prediction model for anthracycline cardiotoxicity in childhood cancer sur
Autor:
Jane Lougheed, Paul F. Kantor, Marie A. Chaix, Rejane Dillenburg, Myriam Lafreniere-Roula, Cedric Manlhiot, Leonard S. Sender, Stacey Marjerrison, Guoliang Meng, Roderick Yao, Ashok Kumar Manickaraj, Anne Christie, Seema Mital, Paul C. Nathan, Shayna Zelcer, Luc Mertens, Mylene Bassal, Neha Parmar, David R. W. Hodgson, James Ellis, Emily Lam, Peter Liu, Oyediran Akinrinade, Herschel Rosenberg, Anastasia Miron
Publikováno v:
Circulation. 142
Background: Despite known clinical and genetic risk factors, predicting anthracycline cardiotoxicity remains challenging. Objective: To develop a risk prediction model for anthracycline cardiotoxicity in childhood cancer survivors. Methods: We perfor
Autor:
G. Manase, Kristen George, A.C. Ouellette, Seema Mital, Ashok Kumar Manickaraj, Jacob Mathew, Judith Wilson, Sarah Bowdin, Leland N. Benson, Laura Zahavich
Publikováno v:
Clinical Genetics. 93:33-40
Background For clinical genetic testing of cardiomyopathy (CMP), current guidelines do not address which gene panels to use: targeted panels specific to a CMP phenotype or expanded (panCMP) panels that include genes associated with multiple phenotypi
Autor:
Carly Ogaki, Elaine Gordon, Herschel Rosenberg, David Chitayat, Lynn Bergin, Christine Dodge, Erwin Oechslin, Seema Mital, Mina Safi, Tanya Papaz, Jennifer Breaton Kyryliuk, Catherine Chant-Gambacort, Liz Burrill, Jane Lougheed, Tapas Mondal, Laura-Lee Walter, Ashok Kumar Manickaraj, John Smythe
Publikováno v:
Pediatrics. 130:e1198-e1205
BACKGROUND: Consenting minors for genetics research and biobanking involves ethical and social challenges. We examined factors influencing participation rates in a population-based biorepository for childhood heart disease. METHODS: Individuals were
Autor:
Caroline Kinnear, Andrew N. Redington, Seema Mital, John Smythe, Aamir Jeewa, Tapas Mondal, Jane Lougheed, Herschel Rosenberg, Cedric Manlhiot, Brian W. McCrindle, Ashok Kumar Manickaraj, Luc Mertens, Glen S. Van Arsdell
Publikováno v:
Pediatric Research. 72:407-413
Background: hypoxia-inducible factor (HIF1A) regulates the myocardial response to hypoxia and hemodynamic load. We investigated the association of variants with right-ventricular (RV) remodeling after tetralogy of Fallot (TOF) repair. Methods: childr
Autor:
Ashok Kumar Manickaraj, Saeed Al Turki, Lisa C.A. D'Alessandro, Dorin Manase, Seema Mital, Matthew E. Hurles
Publikováno v:
BMC Medical Genomics
Background Given the growing use of whole-exome sequencing (WES) for clinical diagnostics of complex human disorders, we evaluated coverage of clinically relevant cardiac genes on WES and factors influencing uniformity and depth of coverage of exonic
Autor:
Linda J. Addonizio, Jaime Alkon, Brian W. McCrindle, Seema Mital, Cedric Manlhiot, Mark K. Friedberg, Ashok Kumar Manickaraj, Caroline Kinnear, Leland N. Benson, Steven D. Colan
Publikováno v:
Pediatric research. 72(6)
Risk factors for diastolic dysfunction in hypertrophic cardiomyopathy (HCM) are poorly understood. We investigated the association of variants in hypoxia-response genes with phenotype severity in pediatric HCM.A total of 80 unrelated patients21 y and
Publikováno v:
Future cardiology. 8(2)
As the population of childhood heart disease survivors grows, a better understanding of the genetic underpinnings of heart disease is needed to improve diagnostics, therapeutics and outcomes. The Trans-Atlantic Research Network, GenomeHeart and The S